ePrivacy and GPDR Cookie Consent by TermsFeed Generator

RESELIGO

3,6MG IMP ISP 1

SÚKL code 0246044
Name of the product RESELIGO
_MA_MEDICATION_DETAIL_INFO_MED_NAME i RESELIGO
Supplement 3,6MG IMP ISP 1
Strenght 3,6MG
Pharmaceutical form Implant in pre-filled syringe
Package 1
Route Subcutaneous use
Language of the pack Czech
Wrap type Pre-filled syringe
Legal status na lékařský předpis
Active substance GOSERELIN ACETATE (GOSERELINI ACETAS)
ATC group L02AE03
ATC group name GOSERELIN
Doping Hormony, růstové faktory a příbuzné látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/.

Marketing authorisation information

Registration Number 56/ 107/16-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 08. 2022
MA Holder Alvogen Pharma Trading Europe EOOD, Sofia
MA Holder country BULHARSKO
Actual MA holder Zentiva, k.s., Praha
Actual MA holder country ČESKÁ REPUBLIKA

Back to list